Long-Term Liabilities to Equity: autonomix.com (AMIX)

Official company branding of Autonomix Medical (AMIX)

This chart illustrates the current share price of Autonomix Medical, Inc. (AMIX) on the GURU.Markets platform, where indicators stand at 0.00, supported by the top management's medtech expertise and strict licensing control. The company is developing advanced oncology catheters currently undergoing clinical trials. However, geopolitical instability is hindering microchip imports and restricting equipment exports to sanctioned regions.

autonomix.com (AMIX): Long-Term Debt to Capital from 02/21/2024 to 10/28/2026

Comprehensive metric breakdowns and analytics for Autonomix Medical Inc. (AMIX)

- price and consensus price forecast:
Market Chart Autonomix|AMIX - Price Target Chart
- market capitalization data:
Market Valuation Autonomix Medical, Inc.|AMIX - Enterprise Value
- book capitalization data:
Net Asset Value per Share Autonomix Medical|AMIX - Book Capitalization|Market Cap to Net Assets Ratio autonomix.com|AMIX - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Autonomix Medical, Inc.|AMIX - Long-Term Debt to Capital|Short-Term Debt to Capital Autonomix|AMIX - Company Debts|Debt to Book Capitalization Ratio Autonomix Medical, Inc.|AMIX - Company Long-Term Debts|Short-Term Debt Volume Autonomix Medical
Comprehensive company analysis:AMIX, autonomix.com
Core merchandise of Autonomix Medical Inc.

Autonomix Medical, Inc. (AMIX) leverages strong pricing power in the minimally invasive chronic pain treatment segment to effectively manage its investment cycle. This indicator is calculated as the ratio of long-term liabilities to total equity. The metric determines the extent to which business development depends on external long-term borrowings. A decrease in this value indicates strengthening financial autonomy and a reduction in interest expenses. The trend of the long-term financial leverage ratio reflects the balance between expansion and balance sheet stability.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio IRADIMED CORPORATION|EMBC - Long-Term Liabilities to Equity|Long-Term Debt to Capital TNDM|AxoGen Inc (AXGN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital SI-BONE Corp (SIBN)|Long-Term Debt to Capital Ratio Orthofix Corp (OFIX)|Bioventus Inc. (BVS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient KIDS (orthopediatrics.com)|Treace Medical Concepts, Inc. - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Blade Air Mobility SRTA|CARL (Carlsmed Corp) - Long-Term Debt to Capital|RXST - Long-Term Liabilities to Capital|Long-Term Debt to Capital clearpointneuro.com|stereotaxis.com (STXS) - Long-Term Debt to Capital Ratio|STIM: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Sight Sciences Inc.|Long-Term Debt to Capital OBIO (Orchestra BioMed)|Long-Term Debt to Equity Ratio anikatherapeutics.com (ANIK)|Long-Term Debt to Capital NSPR (InspireMD, Inc.)|Jin Medical International Ltd. - Long-Term Debt to Capital|VANI - Long-Term Debt to Equity|Xtant Medical Holdings (XTNT) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio NeuroOne Corp NMTC|Modular Medical, Inc. (MODD) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital MYO (Myomo, Inc.)|Long-Term Liabilities to Capital COCH|VVOS: Long-Term Debt to Equity|Long-Term Indebtedness to Equity enVVeno Medical Corporation NVNO|Long-Term Debt to Equity Ratio SINT (Sintx Technologies, Inc.)|Long-Term Debt to Capital Tenon Medical Inc TNON|Long-Term Debt to Capital LFWD (ReWalk Robotics Ltd.)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)